Halevy Orna, Cantley Lewis C
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Exp Cell Res. 2004 Jul 1;297(1):224-34. doi: 10.1016/j.yexcr.2004.03.024.
Hepatocyte growth factor (HGF) promotes the proliferation of adult myoblasts and inhibits their differentiation, whereas insulin-like growth factor I (IGF-I) enhances both processes. Recent studies indicate that activation of the phosphoinositide 3'-kinase (PI3K) pathway promotes myoblast differentiation, whereas activation of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase (MAPK/ERK) promotes proliferation and inhibits their differentiation. This simple model is confounded by the fact that both HGF and IGF-I have been shown to activate both pathways. In this study, we have compared the ability of HGF and IGF-I to activate PI3K and MAPK/ERK in i28 myogenic cells. We find that, although the two stimuli result in comparable recruitment of the p85alpha subunit of PI3K into complexes with tyrosine-phosphorylated proteins, the p85beta regulatory subunit and p110alpha catalytic subunit of PI3K are preferentially recruited into these complexes in response to IGF-I. In agreement with this observation, IGF-I is much more potent than HGF in stimulating phosphorylation of Akt/PKB, a protein kinase downstream of PI3K. In contrast, MAPK/ERK phosphorylation was higher in response to HGF and lasted longer, relative to IGF-I. Moreover, the specific PI3K inhibitor, Wortmannin, abolished MAPK/ERK and Elk-1 phosphorylation in HGF-treated cells, suggesting the requirement of PI3K in mediating the HGF-induced MAPK pathway. UO126, a specific MAPK pathway inhibitor, had no effect on PI3K activity or Akt phosphorylation, implying that at least in muscle cells, the MAPK/ERK pathway is not required for HGF-induced PI3K activation. These results provide a biochemical rationale for the previous observations that HGF and IGF-I have opposite effects on myogenic cells, consistent with studies linking PI3K activation to differentiation and MAPK/ERK activation to proliferation in these cells. Moreover, the finding that PI3K activity is required for HGF-induced MAPK activation suggests its additional role in proliferation, rather than exclusively in the differentiation of adult myoblasts.
肝细胞生长因子(HGF)可促进成体成肌细胞的增殖并抑制其分化,而胰岛素样生长因子I(IGF-I)则可增强这两个过程。最近的研究表明,磷酸肌醇3'-激酶(PI3K)途径的激活可促进成肌细胞分化,而丝裂原活化蛋白激酶/细胞外信号调节蛋白激酶(MAPK/ERK)的激活则促进增殖并抑制其分化。然而,由于HGF和IGF-I均已被证明可激活这两条途径,这一简单模型变得复杂起来。在本研究中,我们比较了HGF和IGF-I在i28成肌细胞中激活PI3K和MAPK/ERK的能力。我们发现,尽管这两种刺激导致PI3K的p85α亚基与酪氨酸磷酸化蛋白形成复合物的募集情况相当,但PI3K的p85β调节亚基和p110α催化亚基在响应IGF-I时优先募集到这些复合物中。与这一观察结果一致,IGF-I在刺激PI3K下游的蛋白激酶Akt/PKB磷酸化方面比HGF更有效。相比之下,相对于IGF-I,HGF诱导的MAPK/ERK磷酸化更高且持续时间更长。此外,特异性PI3K抑制剂渥曼青霉素可消除HGF处理细胞中的MAPK/ERK和Elk-1磷酸化,这表明PI3K在介导HGF诱导的MAPK途径中是必需的。特异性MAPK途径抑制剂UO126对PI3K活性或Akt磷酸化没有影响,这意味着至少在肌肉细胞中,HGF诱导的PI3K激活不需要MAPK/ERK途径。这些结果为先前观察到的HGF和IGF-I对成肌细胞具有相反作用提供了生化依据,这与将PI3K激活与这些细胞的分化以及MAPK/ERK激活与增殖联系起来的研究结果一致。此外,PI3K活性是HGF诱导MAPK激活所必需的这一发现表明其在增殖中具有额外作用,而不仅仅是在成体成肌细胞的分化中起作用。